March 18-21, 2025
San Diego Convention CenterSan Diego, CA, USA Eva Rubio-MarreroSenior Scientist II at AbbVieSpeaker
Profile
Eva Rubio-Marrero is part of Abbvie’s Cell Line Development (CLD) group. Currently she is leading new modalities molecules pipeline programs as well as process research for platform and host cell line improvement. In the past, she contributed to CLD in other pharmaceutical companies (Celgene, Bristol Myers-Squibb) and is very passionate about her work knowing that CLD is one of the first steps to generate new therapeutic treatments for many patients.
Agenda Sessions
Achieving Essential Product Quality & Titre for Multispecific Antibodies
, 2:00pmView Session